BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 23683032)

  • 1. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
    Glover M; O'Shaughnessy KM
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
    Yang CL; Angell J; Mitchell R; Ellison DH
    J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CUL3-KLHL3 E3 ligase complex mutated in Gordon's hypertension syndrome interacts with and ubiquitylates WNK isoforms: disease-causing mutations in KLHL3 and WNK4 disrupt interaction.
    Ohta A; Schumacher FR; Mehellou Y; Johnson C; Knebel A; Macartney TJ; Wood NT; Alessi DR; Kurz T
    Biochem J; 2013 Apr; 451(1):111-22. PubMed ID: 23387299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the renal NaCl cotransporter by the WNK/SPAK pathway: lessons learned from genetically altered animals.
    Ostrosky-Frid M; Castañeda-Bueno M; Gamba G
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F146-F158. PubMed ID: 30089030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPAK and WNK kinases: a new target for blood pressure treatment?
    Glover M; O'shaughnessy KM
    Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):16-22. PubMed ID: 21088576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation regulates NCC stability and transporter activity in vivo.
    Yang SS; Fang YW; Tseng MH; Chu PY; Yu IS; Wu HC; Lin SW; Chau T; Uchida S; Sasaki S; Lin YF; Sytwu HK; Lin SH
    J Am Soc Nephrol; 2013 Oct; 24(10):1587-97. PubMed ID: 23833262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.
    Yang CL; Zhu X; Ellison DH
    J Clin Invest; 2007 Nov; 117(11):3403-11. PubMed ID: 17975670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazide-induced hyponatraemia: epidemiology and clues to pathogenesis.
    Glover M; Clayton J
    Cardiovasc Ther; 2012 Oct; 30(5):e219-26. PubMed ID: 21884020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPAK deficiency corrects pseudohypoaldosteronism II caused by WNK4 mutation.
    Chu PY; Cheng CJ; Wu YC; Fang YW; Chau T; Uchida S; Sasaki S; Yang SS; Lin SH
    PLoS One; 2013; 8(9):e72969. PubMed ID: 24039833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
    Sohara E; Uchida S
    Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WNK-SPAK/OSR1-NCC kinase signaling pathway as a novel target for the treatment of salt-sensitive hypertension.
    Brown A; Meor Azlan NF; Wu Z; Zhang J
    Acta Pharmacol Sin; 2021 Apr; 42(4):508-517. PubMed ID: 32724175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome).
    Glover M; Ware JS; Henry A; Wolley M; Walsh R; Wain LV; Xu S; Van't Hoff WG; Tobin MD; Hall IP; Cook S; Gordon RD; Stowasser M; O'Shaughnessy KM
    Clin Sci (Lond); 2014 May; 126(10):721-6. PubMed ID: 24266877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNK4 is indispensable for the pathogenesis of pseudohypoaldosteronism type II caused by mutant KLHL3.
    Susa K; Sohara E; Takahashi D; Okado T; Rai T; Uchida S
    Biochem Biophys Res Commun; 2017 Sep; 491(3):727-732. PubMed ID: 28743496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay of renal potassium and sodium handling in blood pressure regulation: critical role of the WNK-SPAK-NCC pathway.
    Wu A; Wolley M; Stowasser M
    J Hum Hypertens; 2019 Jul; 33(7):508-523. PubMed ID: 30723251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WNK signalling pathways in blood pressure regulation.
    Murthy M; Kurz T; O'Shaughnessy KM
    Cell Mol Life Sci; 2017 Apr; 74(7):1261-1280. PubMed ID: 27815594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of blood pressure and renal electrolyte balance by Cullin-RING ligases.
    Uchida S
    Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):487-93. PubMed ID: 24992566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Revisiting the NaCl cotransporter regulation by with-no-lysine kinases.
    Bazúa-Valenti S; Gamba G
    Am J Physiol Cell Physiol; 2015 May; 308(10):C779-91. PubMed ID: 25788573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and analysis of the thiazide-sensitive Na+ -Cl- cotransporter (Ncc/Slc12a3) Ser707X knockin mouse as a model of Gitelman syndrome.
    Yang SS; Lo YF; Yu IS; Lin SW; Chang TH; Hsu YJ; Chao TK; Sytwu HK; Uchida S; Sasaki S; Lin SH
    Hum Mutat; 2010 Dec; 31(12):1304-15. PubMed ID: 20848653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
    Nishida H; Sohara E; Nomura N; Chiga M; Alessi DR; Rai T; Sasaki S; Uchida S
    Hypertension; 2012 Oct; 60(4):981-90. PubMed ID: 22949526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension, dietary salt intake, and the role of the thiazide-sensitive sodium chloride transporter NCCT.
    Glover M; Zuber AM; O'Shaughnessy KM
    Cardiovasc Ther; 2011 Feb; 29(1):68-76. PubMed ID: 21167012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.